We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH) (TIM01)

This study is currently recruiting participants.
Verified October 2017 by Chiara Melloni, Duke University Medical Center
Sponsor:
ClinicalTrials.gov Identifier:
NCT02913612
First Posted: September 26, 2016
Last Update Posted: October 3, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
The EMMES Corporation
Information provided by (Responsible Party):
Chiara Melloni, Duke University Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 28, 2018
  Estimated Primary Completion Date: September 28, 2018 (Final data collection date for primary outcome measure)